We don’t support this browser anymore.
This means our website may not look and work as you would expect. Read more about browsers and how to update them here.

Skip to main content
  • Register
  • Help
  • Contact us

Vifor Pharma AG (VIFN) CHF0.01

Sell:160.25 CHF Buy:164.00 CHF Change: 0.60 CHF (0.37%)
Market closed |  Prices as at close on 28 January 2022 | Switch to live prices |
Takeover

Vifor Pharma AG CHF0.01

Type:
Takeover
Shareholder action required:
Yes
Status:
Client deadline
Details (last updated 27 Jan 2022)

CSL Ltd recently announced the terms of a takeover offer to acquire Vifor Pharma AG. Under the terms of the Tender Offer holders of Vifor Pharma AG Shares have been offered USD179.25 for each Share held.

 

What are my options?

 

Option 1 – Do nothing. You are not required to take any action at this time. Please note that if the takeover by CSL Ltd is successful, the company may gain the ability to delist Vifor Pharma AG or compulsorily acquire your shares.

 

Option 2 – Accept the Offer. You can give an instruction to accept the Tender Offer of USD179.25 for each Vifor Pharma AG Share held. Following receipt of your instruction your Shares would be submitted in acceptance of the Offer.

 

You have until noon on Monday 28 February 2022 to decide if you want to accept the offer.

 

Full details of this event will be sent to qualifying Hargreaves Lansdown clients by either post or secure message. Please note that any instruction you give must be based on the full details provided in the letter and not on the summary information outlined above.

×
Sell:160.25 CHF
Buy:164.00 CHF
Change: 0.60 CHF (0.37%)
Market closed |  Prices as at close on 28 January 2022 | Switch to live prices |
Takeover

Vifor Pharma AG CHF0.01

Type:
Takeover
Shareholder action required:
Yes
Status:
Client deadline
Details (last updated 27 Jan 2022)

CSL Ltd recently announced the terms of a takeover offer to acquire Vifor Pharma AG. Under the terms of the Tender Offer holders of Vifor Pharma AG Shares have been offered USD179.25 for each Share held.

 

What are my options?

 

Option 1 – Do nothing. You are not required to take any action at this time. Please note that if the takeover by CSL Ltd is successful, the company may gain the ability to delist Vifor Pharma AG or compulsorily acquire your shares.

 

Option 2 – Accept the Offer. You can give an instruction to accept the Tender Offer of USD179.25 for each Vifor Pharma AG Share held. Following receipt of your instruction your Shares would be submitted in acceptance of the Offer.

 

You have until noon on Monday 28 February 2022 to decide if you want to accept the offer.

 

Full details of this event will be sent to qualifying Hargreaves Lansdown clients by either post or secure message. Please note that any instruction you give must be based on the full details provided in the letter and not on the summary information outlined above.

×
Sell:160.25 CHF
Buy:164.00 CHF
Change: 0.60 CHF (0.37%)
Market closed |  Prices as at close on 28 January 2022 | Switch to live prices |
Takeover

Vifor Pharma AG CHF0.01

Type:
Takeover
Shareholder action required:
Yes
Status:
Client deadline
Details (last updated 27 Jan 2022)

CSL Ltd recently announced the terms of a takeover offer to acquire Vifor Pharma AG. Under the terms of the Tender Offer holders of Vifor Pharma AG Shares have been offered USD179.25 for each Share held.

 

What are my options?

 

Option 1 – Do nothing. You are not required to take any action at this time. Please note that if the takeover by CSL Ltd is successful, the company may gain the ability to delist Vifor Pharma AG or compulsorily acquire your shares.

 

Option 2 – Accept the Offer. You can give an instruction to accept the Tender Offer of USD179.25 for each Vifor Pharma AG Share held. Following receipt of your instruction your Shares would be submitted in acceptance of the Offer.

 

You have until noon on Monday 28 February 2022 to decide if you want to accept the offer.

 

Full details of this event will be sent to qualifying Hargreaves Lansdown clients by either post or secure message. Please note that any instruction you give must be based on the full details provided in the letter and not on the summary information outlined above.

×
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.
Open:
164.00 CHF
Trade high:
164.30 CHF
Year high:
164.30 CHF
Market capitalisation
Market cap.
:
10.66 bn CHF
Previous close:
164.00 CHF
Trade low:
163.05 CHF
Year low:
102.30 CHF
Shares in issue
Shares
:
64.86 m
Previous:
1.15 CHF (0.71%)
Previous:
1.15 CHF
Volume:
n/a
Dividend yield:
1.22%
Currency:
CHF
Data delayed by at least 15 minutes.

Ready to invest?

To buy shares in , you'll need to have an account.
Try our handy filter to explore the different options.

Compare accounts

Ready to invest?

To invest in , you'll need to open an account.
Try our handy filter to find which one suits you best.

Compare accounts

Important Documents

There are no documents available for this stock.

Dividend information for this stock is not available.

Dividend information for this stock is not available.

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Prices provided by Reuters. Charts provided by Factset. 'Broker forecast' and 'Recent trades' provided by MoneyAM. News and fundamental data provided by Digital Look. Exchange disclaimer

Share

The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.

Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.